This trial will test a new protocol using Near Infrared Spectroscopy to diagnose and measure the severity of Major Depressive Disorder.
6 Primary · 3 Secondary · Reporting Duration: Each measurement is over 10 to 15 mins long, taken during the performance of VFT and CHR, on the day of initiation of treatment for MDD, but before the treatment is given.
1 Treatment Group
1 of 1
90 Total Participants · 1 Treatment Group
Primary Treatment: Depressed Patients · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there still vacancies available for participants in this research project?
"According to the data posted on clinicaltrials.gov, this medical study is not actively looking for participants at present. The trial was initially launched on April 1st 2019 and has been edited as recently as August 10th 2020. Though no longer recruiting patients, 1317 other trials are currently in need of volunteers." - Anonymous Online Contributor